Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results